Medtech

BTIG to Host Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference on February 13 - 14, 2024

Retrieved on: 
Wednesday, February 7, 2024

BTIG announced today the MedTech, Digital Health, Life Science and Diagnostic Tools Conference will take place on Tuesday, February 13 through Wednesday, February 14, 2024.

Key Points: 
  • BTIG announced today the MedTech, Digital Health, Life Science and Diagnostic Tools Conference will take place on Tuesday, February 13 through Wednesday, February 14, 2024.
  • “We are excited to host the event in Snowbird and eagerly anticipate the engagement and shared insights from our distinguished guests.”
    For more information about the conference, please email [email protected] .
  • To access BTIG insights, contact a BTIG representative or log in to research.btig.com.
  • BTIG’s Corporate Access program hosts client events across the consumer, energy and infrastructure, financials, healthcare, real estate and technology sectors.

KARL STORZ unifies its US organizations under a central management team, Sonal Matai named US President

Retrieved on: 
Tuesday, February 6, 2024

Sonal Matai, who has led the US commercial business for two years, has been named President of KARL STORZ in the United States and will lead the effort to bring this ambitious transformation to life.

Key Points: 
  • Sonal Matai, who has led the US commercial business for two years, has been named President of KARL STORZ in the United States and will lead the effort to bring this ambitious transformation to life.
  • View the full release here: https://www.businesswire.com/news/home/20240206848760/en/
    Sonal Matai will head KARL STORZ United States, a new organization formed by the consolidation of three previously separate KARL STORZ subsidiaries.
  • (Photo: Business Wire)
    “The US is the world’s largest medical device market and also the largest market for KARL STORZ,” said Sonal Matai, US President of KARL STORZ.
  • Our suppliers and vendor partners will benefit from streamlined interactions with an integrated KARL STORZ in the US,” Matai added.

MedTech Momentum Celebrates a Decade of Success with a Bold Rebranding and a New Website

Retrieved on: 
Tuesday, February 6, 2024

ALTAMONTE SPRINGS, Fla., Feb. 6, 2024 /PRNewswire-PRWeb/ -- Marking a decade of innovation in healthcare marketing, MedTech Momentum, Inc. proudly announces its vibrant rebranding and the debut of a redesigned website. This landmark anniversary celebrates the company's journey in delivering groundbreaking marketing solutions, significantly benefiting its client partners. MedTech Momentum's dedication extends beyond traditional agency roles, positioning itself as a key healthcare communication advisor committed to advancing its clients' success.

Key Points: 
  • ALTAMONTE SPRINGS, Fla., Feb. 6, 2024 /PRNewswire-PRWeb/ -- Marking a decade of innovation in healthcare marketing, MedTech Momentum, Inc. proudly announces its vibrant rebranding and the debut of a redesigned website.
  • MedTech Momentum's dedication extends beyond traditional agency roles, positioning itself as a key healthcare communication advisor committed to advancing its clients' success.
  • With its rebranding and the launch of the new website, MedTech Momentum is poised to further its legacy as a leader in healthcare marketing.
  • For more information about MedTech Momentum and to explore the new website, please visit www.medtechmomentum.com .

Spectral AI to Participate in the 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Retrieved on: 
Tuesday, February 6, 2024

DALLAS, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it will participate in the BTIG Snowbird MedTech, Digital Health, Life Science & Diagnostic Tools Conference.

Key Points: 
  • DALLAS, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it will participate in the BTIG Snowbird MedTech, Digital Health, Life Science & Diagnostic Tools Conference.
  • Management will host investor meetings February 13-14, 2024.
  • Please contact your BTIG representative if you would like to schedule a virtual or in-person meeting with Spectral AI during the conference.
  • For more information about the conference please refer to the BTIG website .

Mitchell Rock Named President of UFP Technologies

Retrieved on: 
Tuesday, February 6, 2024

NEWBURYPORT, Mass., Feb. 06, 2024 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today announced the appointment of Mitchell Rock as President of the Company.

Key Points: 
  • NEWBURYPORT, Mass., Feb. 06, 2024 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), an innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today announced the appointment of Mitchell Rock as President of the Company.
  • Rock has been serving as President of the Company’s MedTech business.
  • R. Jeffrey Bailly will continue in his capacity as Chairman and Chief Executive Officer.
  • “He is hard-working, well-known, and well-respected throughout our industry and within UFP Technologies.

ODAIA Attracts Top Talent to Accelerate Next Phase of Innovation and Customer Success

Retrieved on: 
Tuesday, February 6, 2024

TORONTO, Feb. 6, 2024 /PRNewswire/ -- ODAIA today announced it expanded its strategic alliances, product management, and marketing leadership teams to help address customers' most strategic challenges in commercial operations. The company is bringing together accomplished life sciences industry experts and proven SaaS technology leaders to accelerate innovation and customer success in Customer Science, an emerging business discipline that integrates data science, behavioral science, and AI to drive healthcare professional (HCP) engagement.

Key Points: 
  • The company is bringing together accomplished life sciences industry experts and proven SaaS technology leaders to accelerate innovation and customer success in Customer Science , an emerging business discipline that integrates data science, behavioral science, and AI to drive healthcare professional (HCP) engagement.
  • The ODAIA Customer Science cloud solution, MAPTUAL , gives sales and marketing advanced, AI-driven insights and predictions for a comprehensive understanding of HCP prescribing patterns and behavioral trends.
  • ODAIA continues to attract top talent to drive the next phase of innovation in Customer Science and help advance pharma customers' commercial strategies.
  • He leads the development of ODAIA industry solutions and market strategy, as well as strategic relationships with customers and partners.

Venus Concept Inc. to Participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 13th

Retrieved on: 
Tuesday, February 6, 2024

TORONTO, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management will participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference, which is being held at the Cliff Lodge in Snowbird, UT from February 13th – 14th.

Key Points: 
  • TORONTO, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management will participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference, which is being held at the Cliff Lodge in Snowbird, UT from February 13th – 14th.
  • Management will participate in virtual investor meetings on Tuesday, February 13th.
  • There will be no formal presentation.

Premier Diversified Holdings Inc. Announces Cease Trade Order and Provides Update on the Proposed Acquisition of AJA Health and Wellness Ltd., Assured Diagnosis Inc., and AJA Therapeutics Inc.

Retrieved on: 
Monday, February 5, 2024

VANCOUVER, British Columbia, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Premier Diversified Holdings Inc. ("PDH" or the "Company") (TSXV:PDH) announces that further to the press release dated January 18, 2024, whereby the Company announced the filing of an application seeking a management cease trade order (“MCTO”) from the British Columbia Securities Commission (“BCSC”) due to its inability to file its annual financial statements for the year ending September 30, 2023 including the related management’s discussion and analysis and certifications from the CEO and CFO (the “Annual Filings”), the BCSC will issue a cease trade order against PDH (the “CTO”).

Key Points: 
  • The Corporation continues to pursue the acquisitions of AJA Health and Wellness Ltd. ("AJA Health"), AJA Therapeutics Inc. ("ATI"), and Assured Diagnosis Inc. ("ADI", and together with PDH, AJA Health, and ATI, the "Parties").
  • The Acquisition, subject to certain conditions and applicable shareholder and regulatory approvals, will result in a reverse takeover of PDH.
  • There can be no assurance that the Acquisition will be completed as proposed or at all.
  • AJA Health and ADI are diligently working on having audits completed on their financial statements.

Tactile Medical to Participate in Upcoming Investor Conferences in February and March

Retrieved on: 
Monday, February 5, 2024

MINNEAPOLIS, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that management will participate in the following upcoming investor conferences:

Key Points: 
  • MINNEAPOLIS, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that management will participate in the following upcoming investor conferences:
    The BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference at the Cliff Lodge in Snowbird, UT.
  • Management will participate in investor meetings on Tuesday, February 13th.
  • The Oppenheimer 34th Annual Healthcare MedTech & Services Conference which is being held virtually.
  • Management will participate in a virtual fireside chat at 2:40 p.m. Eastern Time on Tuesday, March 12th.

Olympus Closes the Acquisition of Korean Gastrointestinal Stent Company, Taewoong Medical Co., Ltd

Retrieved on: 
Wednesday, January 24, 2024

[2]

Key Points: 
  • [2]
    Taewoong Medical offers a variety of medical devices including metallic stents designed for biliary tract, esophagus, colon, and duodenum treatments.
  • Taewoong Medical will join Olympus' Therapeutic Solutions Division, helping Olympus become a comprehensive solutions provider in the GI market with varied GI EndoTherapy solutions by bringing together talent and technology.
  • The addition of Taewoong Medical to Olympus' portfolio will contribute to the company's focus on enhancing patient care pathways.
  • Comment from Kyong-min Shin, President and CEO of Taewoong Medical: "As a leading medical company, Taewoong Medical manufactures a vast range of medical equipment of our own designs.